Abstract

Aims: Long non-coding RNA IRAIN (lncRNA IRAIN) plays a critical role in numerous malignancies. However, the function of lncRNA IRAIN in renal carcinoma (RC) remains enigmatic. The purpose of this study is to characterize the effects of lncRNA IRAIN on RC progression.Methods: The expression pattern of lncRNA IRAIN and the vascular endothelial growth factor A (VEGFA) in RC tissues and cells was characterized by RT-qPCR and Western blot analysis. The roles of lncRNA IRAIN and VEGFA in the progression of RC were studied by gain- or loss-of-function experiments. Bioinformatics data analysis was used to predict CpG islands in the VEGFA promoter region. MSP was applied to detect the level of DNA methylation in RC cells. The interaction between lncRNA IRAIN and VEGFA was identified by RNA immunoprecipitation and RNA-protein pull down assays. Recruitment of DNA methyltransferases (Dnmt) to the VEGFA promoter region was achieved by chromatin immunoprecipitation. The subcellular localization of lncRNA IRAIN was detected by fractionation of nuclear and cytoplasmic RNA. Cell viability was investigated by CCK-8 assay, cell migration was tested by transwell migration assay, and apoptosis was analyzed by flow cytometry. The expression of epithelial–mesenchymal transition-related and apoptotic factors was evaluated by Western blot analysis. Finally, the effect of the lncRNA IRAIN/VEGFA axis was confirmed in an in vivo tumor xenograft model.Results: LncRNA IRAIN was poorly expressed in RC tissues and cells with a primary localization in the nucleus, while VEGFA was highly expressed. Overexpression of lncRNA IRAIN or knockdown of VEGFA inhibited cell proliferation and migration and induced the apoptosis of RC cells. Bioinformatics analysis indicated the presence of CpG islands in the VEGFA promoter region. Lack of methylation at specific sites in the VEGFA promoter region was detected through MSP assay. We found that lncRNA IRAIN was able to inhibit VEGFA expression through recruitment of Dnmt1, Dnmt3a, and Dnmt3b to the VEGFA promoter region. LncRNA IRAIN was also able to suppress RC tumor growth via repression of VEGFA in an in vivo mouse xenograft model.Conclusion: Our data shows that by downregulating VEGFA expression in RC, the lncRNA IRAIN has tumor-suppressive potential.

Highlights

  • Renal carcinoma (RC) comprised several histological subtypes, including clear cells, type 1 papillary carcinoma, and type 2 papillary carcinoma [1], each subtype being characterized by a unique molecular morphology [2]

  • We found that Long non-coding RNA (lncRNA) IRAIN was able to inhibit vascular endothelial growth factor A (VEGFA) expression through recruitment of Dnmt1, Dnmt3a, and Dnmt3b to the VEGFA promoter region

  • The results showed that in comparison with HK-2 cells, lncRNA IRAIN was poorly expressed in Caki-1, A498, 786-O, and 769-P cells (p < 0.05; Figure 1C)

Read more

Summary

Introduction

Renal carcinoma (RC) comprised several histological subtypes, including clear cells, type 1 papillary carcinoma, and type 2 papillary carcinoma [1], each subtype being characterized by a unique molecular morphology [2]. Renal cell carcinoma (RCC) is present in more than 90% of all kidney cancers [3], with the most common histological subtype, clear cell RCC (ccRCC), appearing in 70–80% of RCC cases [4]. Risk factors such as smoking, obesity, and high blood pressure contribute to the occurrence of RC [5]. According to our bioinformatics predictions, lncRNA IRAIN targets the vascular endothelial growth factor A (VEGFA), which provides a better understanding of how IRAIN exerts its function

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call